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group (PD150606 group). To achieve a suitable simulated H/R, car-
diomyocytes were incubated with serum-free and glucose-free me-
dium under conditions of hypoxia for 20 min, then they were returned
to a normoxic environment with the normal culture medium at 37C
for 2 hours. The viability of cultured cardiomyocytes was examined
using trypan blue exclusion test. The cytosolic cytochrome c levels
were determined using an ELISA kit. The ﬂuorimetric caspase-3 kit
was assayed to measure its activity in the cardiomyocytes. The Suc-
LLVY-AMC was used as a ﬂuorescence substrate to measure of calpain
activity of cardiomyocytes. Formation of 2-hydroxyethidium (2-EOH)
in cardiomyocytes was measured by HPLC to quantify superoxide
production.
RESULTS After subjected to I/R, the viable rod-shaped cells were
decreased to 37.8% in I/R group when compared with the control
group (75.6%), while the calpain inhibitor PD150606 prevented 15% of
the rod-shaped cells against H/R-induced cell death. Similarly,
compared to I/R group, PD150606 inhibited myocardial apoptosis by
decreasing caspase-3 activity 65% and cytochrome c release 47%.
Calpain activity was increased 58% in the H/R-cultured car-
diomyocytes, yet blunted to 23% by PD150606. Compared to control
group, the superoxide (2-EOH) was overproduced 5.43-fold and 4.22-
fold, respectively, in I/R and PD150606 group. 2-EOH was partially
prevented by PD150606.
CONCLUSIONS Calpain inhibitor PD150606 can effectively reduce
H/R injury by reducing oxidative stress mediated myocardial
apoptosis. It is plausible that calpain inhibition would be an effective
method for protecting the cardiomyocytes from H/R injury.GW26-e2452
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OBJECTIVES To construct the short hairpin small interfering
RNA(shRNA) eukaryotic expression vector speciﬁc to mouse lectin like
oxidized low density lipoprotein receptor 1(LOX-1) Gene and to
observe its silencing effect on LOX-1 in RAW264.7 cells.
METHODS (1) The pLOX-1-shRNA expression vector was constructed
by gene recombination, Then transfected into the cultured RAW264.7
cells. At 48 h after Transfection, the expression of LOX-1 mRNA in
RAW264.7 cells were determined by semi-quantitative RT-PCR, the
expression of LOX-1 proteins examined by Western blot.
(2) Oil Red O Dyeing experiment was used to show the cellular lipid
droplets in lipid-loaded cells. The method of cholesterol oxidase
analysis was performed to determine the content of cellular choles-
terol. the ability of uptake Dil-ox-LDL in RAW264.7 cells was assayed
by ﬂuorescence microscopy.
RESULTS pLOX-1-shRNA expression vector was successfully con-
structed. Transfection of pLOX-1-shRNA expression vector into
RAW264.7 cells down regulated the expression level of LOX-1 gene, as
compared with the control Group, transfection of the RAW264.7 cells
with LOX 1-shRNA led to a remarkable reduction of the number
macrophages transformed into foam cell, and could suppress the
uptake of ox-LDL.
CONCLUSIONS The pLOX-1-shRNA expression vector can inhibit The
expression of LOX 1 in RAW264.7 cells and the transformation of the
macrophages into foam, which may he beneﬁcial in searching new
gene therapy of atherosclerosis.
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OBJECTIVES To provide experimental basis for revealing the mech-
anism of yang xin shi in prevention and treatment of coronary heart
disease ,we observe its effects on macrophage inﬂammatory activa-
tion and polarity switch by culturing the human monocytic cell line
THP-1 with Yang Xin Shi.
METHODS Human THP-1 cells were differentiated into macrophages
by the addition of 160 nmol/l phorbol 12-myristate 13-acetate(PMA) for24 h. We treated macrophages with different concentrations of yang
xin shi (10 mg/L, 50 mg/L, 100 mg/L, 200 mg/L) for 12 h, then we
stimulated these cells by OX-LDL and detected the secretion of
monocyte chemotactic protein 1 (MCP-1) and macrophage migration
inhibition factor (MIF) by Enzyme-linked immunosorbent assay
(ELISA), and the membrane molecule CD16, CD68 were tested by ﬂow
cytometry.
RESULTS 1. Yang xin shi could inhibit the expression of MCP-1 and
MIF from the cell culture supernatants as a dose-dependent manner.
With the increasing concentrations of Yang xin shi, the secretion of
MCP-1 (control: 33.302.37 pg/mL; 10 mg/mL: 26.781.48 pg/mL;
50 mg/L:25.732.25pg/mL;100 mg/L:9.952.09pg/mL; 200mg/L:
8.531.37pg/mL) and MIF (control: 18.650.15 ng/mL; 10 mg/L:
15.500.27ng/mL; 50 mg/L: 9.070.26ng/mL; 100 mg/L: 4.850.12ng/
mL; 200mg/L: 4.580.36ng/mL) decreased. The difference was sta-
tistically signiﬁcant.
2. Yang xin shi could change the expression of CD16 and CD68 as a
dose-dependent manner, the mean ﬂuorescence intensity (MFI) of
100mg/L group could signiﬁcantly up-regulated the expression of
CD16, CD68 (CD16: 96 vs 71.2; CD68: 91.6 vs 54.7). As the concentration
increased, the expression of CD16, CD68 were down-regulated in
200mg/L group (CD16:80.6,CD68:72.1).
CONCLUSIONS Yang xin shi may execute its anti-atherosclerotic ef-
fect by inhibiting macrophage inﬂammatory activation and affecting
polarity switch.
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Hongjian Lian, Wei Wang
Beijing University of Chinese Medicine
OBJECTIVES Transverse aortic constriction is widely used to induce
heart failure by increasing afterload. It was believed that different
pathological and functional changes may appear during a long period
after TAC surgery. But comprehensive and dynamic researches about
TAC model were still limited. In this study, we try to explore these
dynamic pathological and functional changes in TAC mice by multi-
measurement during 16 weeks.
METHODS 150 healthy KM mice were divided into two groups
randomly: TAC (operated with TAC) group (n¼90) and Sham-opera-
tion (SH) group (n¼60). Pathological, functional detection was per-
formed at 6 different time-points, including 2 weeks, 4 weeks, 6
weeks, 8 weeks, 12 weeks and 16 weeks after surgery. Symptoms and
signs of animals were observed and recorded. Echocardiography was
used in evaluation of cardiac function and structure by detecting left
ventricular mass (LVM) and left ventricular mass index (LVMI),
measuring the thickness of anterior or posterior wall, the diameter
and volume of left ventricular at both systolic and diastolic stage and
analyzing left ventricular ejection fraction (LVEF), left ventricular
fractional shortening (LVFS). After gross anatomy and general obser-
vation of heart, the heart was weighed and heart/body index was
calculated. Haematoxylin-eosin stain and Masson stain were per-
formed to show the histological of heart.
RESULTS (1) Compared with SH, LVM, LVMI and heart/body index of
TAC group increased signiﬁcantly (P＜0.05, P ＜0.01) from 2 to 16
weeks after surgery. LVEF started to reduce after 6 weeks (P ＜0.05,
P＜0.01). LVFS started to reduce signiﬁcantly after 4 weeks (P＜0.05,
P ＜0.01). The thickness of left ventricular wall started to thicken
signiﬁcantly after 2 weeks (P ＜0.05, P ＜0.01). Left ventricular end-
systolic volume and left ventricular internal diameter (systolic) star-
ted to increase signiﬁcantly after 6 weeks (P ＜0.05, P ＜0.01).
Left ventricular internal diameter (diastolic) and left ventricular
end-diastolic volume started to reduce signiﬁcantly after 12 weeks
(P ＜0.05, P ＜0.01).
(2) Heart tissue morphology showed vessel wall thickening after 2
weeks. Myocardial hypertrophy appeared after 4 weeks. Lesions
aggravated with widened myocardial ﬁber gap after 12 weeks.
(3) Manifestations of pulmonary congestion were visually observed
at each time point. Animals of TAC group were observed with loco-
motor activity decrease after 4 weeks, swollen soles after 8 weeks, and
respiratory distress followed by sudden death after 12 weeks.
CONCLUSIONS Transverse aortic constriction could successfully
induce elevated afterload of KM mice and cause Myocardial Hyper-
trophy/Heart failure in mice. From 2 to 8 weeks after surgery, left
ventricular hypertrophy appeared in the TAC mice. According to
clinical judgment in the diagnosis of congestive heart failure, this
period belonged to pre-clinical stage of heart failure. Similarly,
